The Miami Entrepreneur

Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug

Read Time:6 Second

Lars Fruergaard Jørgensen’s remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move
Next post Spacecraft maker Terran Orbital ‘looking at everything,’ CEO says after Lockheed Martin takeover bid